1
|
Ozgen G, Turk Gezer M, Armagan G, Ballar Kirmizibayrak P, Yalcin A, Ozer O, Ozkirim Arslan B, Kayar G, Dude UK, Kaymak Ozdemir A. Establishment and Validation of an Automated System for the Antifactor IIa Assay: A Case Study of Potency Assessment of a Pharmaceutical Gel Formulation. ACS OMEGA 2024; 9:18366-18374. [PMID: 38680345 PMCID: PMC11044257 DOI: 10.1021/acsomega.4c00290] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Grants] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Received: 01/09/2024] [Revised: 03/26/2024] [Accepted: 04/01/2024] [Indexed: 05/01/2024]
Abstract
Antithrombotic agents and anticoagulant drugs, such as those from the heparin family, are employed in clinical settings for the prevention and treatment of clotting, thromboembolism, and wound healing. The potency assessment of antithrombotic agents is typically conducted using antifactor IIa assay with manual systems which are time-consuming and often lack repeatability. Here, we present a novel automated system that significantly enhances assay repeatability, attaining an outstandingly low relative standard deviation (RSD) % of only 0.6% for repeatability. This system has been applied to a pharmaceutical gel formulation for wound healing developed by Abdi Ibrahim Pharmaceuticals R&D Center as a case study for validation. The automated system demonstrated substantial improvements over manual systems in linearity (R2 = 0.9927), precision, accuracy, specificity, and robustness. The system aligns with the European Pharmacopoeia specifications, promising to enhance quality control across pharmaceutical formulations and conduct absorbance-based end-point assays within the pharmaceutical industry while offering increased throughput and cost-effectiveness.
Collapse
Affiliation(s)
- Gokselin Ozgen
- Abdi
İbrahim Pharmaceuticals Research & Development Center (R&D), Istanbul 34538, Türkiye
| | - Merve Turk Gezer
- Abdi
İbrahim Pharmaceuticals Research & Development Center (R&D), Istanbul 34538, Türkiye
| | - Guliz Armagan
- Faculty
of Pharmacy, Department of Biochemistry, Ege University, Bornova, Izmir 35040, Türkiye
| | | | - Ayfer Yalcin
- Faculty
of Pharmacy, Department of Biochemistry, Ege University, Bornova, Izmir 35040, Türkiye
| | - Ozgen Ozer
- Faculty
of Pharmacy, Department of Pharmaceutical Technology, Ege University, Bornova, Izmir 35040, Türkiye
| | - Banu Ozkirim Arslan
- Abdi
İbrahim Pharmaceuticals Research & Development Center (R&D), Istanbul 34538, Türkiye
| | - Gonul Kayar
- Abdi
İbrahim Pharmaceuticals Research & Development Center (R&D), Istanbul 34538, Türkiye
| | - Udaya Kumar Dude
- Abdi
İbrahim Pharmaceuticals Research & Development Center (R&D), Istanbul 34538, Türkiye
| | - Aysegul Kaymak Ozdemir
- Faculty
of Pharmacy, Department of Biochemistry, Ege University, Bornova, Izmir 35040, Türkiye
| |
Collapse
|
2
|
Evaluation of the changes in hemostatic parameters induced by etoricoxib in rat model. Blood Coagul Fibrinolysis 2008; 19:254-7. [DOI: 10.1097/mbc.0b013e3282f2b5ea] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|